1. Jarad, S., A. Akour, W. Khreisat and A. El-Shammari, 2021. Clinical pharmacist-led educational tool effect on pediatric patients with epilepsy in Jordan. Authorea, 10.22541/au.161277696.69995842/v1.
   CrossRef  |  Direct Link  |  
2. Alrabadi, N.N., L.N. AL-Eitan, I.M. Al-Dalalah, A.K. Elshammari and W.H. Khreisat et al., 2020. Withdrawn: evaluation of the factors that may contribute to the responsiveness of anti-epileptic treatments in pediatric patients, a study from Jordan. Neurosci. Res., 10.1016/j.neures.2020.07.013.
   CrossRef  |  Direct Link  |  
3. AL-Eitan, L.N., I.M. Al-Dalala, A.K. Elshammari, W.H. Khreisat and A.F. Nimri et al., 2020. Genetic association of epilepsy and anti-epileptic drugs treatment in Jordanian patients. Pharmacogenomics Pers. Med., 13: 503-510.
   CrossRef  |  Direct Link  |  
4. AL-Eitan, L.N., I.M. Al-Dalalah, M.M. Mustafa, M.A. Alghamdi, A.K. Elshammari, W.H. Khreisat, M.N. Al-Quasmi and H.A. Aljamal, 2019.

   Genetic polymorphisms of CYP3A5, CHRM2, and ZNF498 and their association with epilepsy susceptibility: a pharmacogenetic and case–control study

   . Pharm. Personal. Med., Volume 12: 225-233.
   CrossRef  |  Direct Link  |  
5. AL-Eitan, L.N., I.M. Al-Dalalah, M.M. Mustafa, M.A. Alghamdi, A.K. Elshammari, W.H. Khreisat and H.A. Aljamal, 2019.

   Effects of MTHFR and ABCC2 gene polymorphisms on antiepileptic drug responsiveness in Jordanian epileptic patients

   . Pharm. Personal. Med., 12: 87-95.
   CrossRef  |  Direct Link  |  
6. AL-Eitan, L., I. Al-Dalalah, A. Elshammari, W. Khreisat and A. Almasri, 2018. The impact of potassium channel gene polymorphisms on antiepileptic drug responsiveness in arab patients with epilepsy. J. Pers. Med., 10.3390/jpm8040037.
   CrossRef  |  Direct Link  |  
7. Khreisat, W.H., 2011. Electroencephalogram in childhood neurological disorders. Egypt. J. Hospital Med., 44: 371-379.
8. Khreisat, W.H., 2011. Clinical profile of infants with Hypsarrhythmia. Acta Inform. Med., 19: 149-152.
   Direct Link  |  
9. Khreisat, W.H., 2011. Clinical profile of childhood focal epilepsies in Jordan. Gaziantep Med. J., 17: 129-132.
10. Al Wahadneh, A.M., A.F. Abu Zeid and W.H. Khreisat, 2007. Juvenile idiopathic oligoarthritis: Analysis of 42 cases in Jordan. EMHJ-East. Mediter. Health J., 13: 461-464.
    Direct Link  |  
11. Khreisat, W.H., 2006. Clinical profile of epilepsy during the first two years of life. Pak. J. Med. Sci., 22: 55-59.
12. Al Ahwat, M.S., 2005. Risk factors of birth asphyxia: A study at prince Ali Ben Al-Hussein hospitel, Jordan. Pak. J. Med. Sci., 21: 30-34.
13. Khreisat, W.H., 2000. The role of tea in iron dedicieny anemia. Basrah Med. J., 21: 730-734.
14. Khreisat, W.H., 2000. The risk factors for persistat diarrhea. Basrah Med. J., 22: 813-817.
15. Khreisat, W.H., 1999. Metaclorpramide abuse in infants. Iraq Med. J., 38: 307-308.